Inspire IVF Public Company Limited Begins Trading on the Market for Alternative Investment (mai)
Inspire IVF Public Company Limited Begins Trading on the Market for Alternative Investment (mai)
Inspire IVF Public Company Limited (“IVF”) officially celebrated its first day of securities trading on the Market for Alternative Investment (mai) with the opening ceremony of its first trading day.
IVF is a provider of comprehensive fertility treatment services, offering consultations, infertility treatment planning, and personalized treatment options tailored to each individual’s needs, including advanced assisted reproductive technologies such as ICSI and IUI to help improve pregnancy success rates for couples. The company is supported by a team of experienced physicians and scientists specializing in reproductive technology, with its service facility located at Ploenchit Center, covering approximately 1,000 square meters.
The company operates through two main business segments:
- Fertility Treatment Services – Providing infertility treatments and related services, including health promotion programs for couples undergoing fertility treatment, embryo genetic testing, and fertility preservation services.
- Preventive and Regenerative Medicine Services – Providing preventive healthcare and wellness services for the general public.
The company’s target customers are primarily international clients, accounting for approximately 80–90% of its customer base.
